Mammaglobin B expression in human endometrial cancer

International Journal of Gynecological Cancer

Volumn 18, Issue 5, 2008, Pages 1090-1096

  Tassi, R A ^a   Bignotti, E ^a   Falchetti, M ^a   Calza, S ^a   Ravaggi, A ^a   Rossi, E ^a   Martinelli, F ^a   Bandiera, E ^a   Pecorelli, S ^a   Santin, A D ^a,b,c  

^a UNIVERSITY OF BRESCIA   (Italy)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Differential expression; Endometrioid endometrial cancer; Mammaglobin B; Tumor marker

Indexed keywords

MAMMAGLOBIN; MAMMAGLOBIN B; MAMMAGLOBIN B2; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

ADULT; AGED; AGED, 80 AND OVER; ENDOMETRIAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEALTH; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MYELIN PROTEINS; NEOPLASM STAGING; PROTEOLIPIDS; UTEROGLOBIN;

EID: 51749099388     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.01137.x     Document Type: Article

References (24)

1. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983 15 : 10 7.
2. Dvalishvili I, Charkviani L, Turashvili G, Burkadze G. Clinical characteristics of prognostic factors in uterine endometrioid adenocarcinoma of various grade. Georgian Med News 2006 132 : 24 7.
3. Kuwabara Y, Susumu N, Banno K et al. Clinical characteristics of prognostic factors in poorly differentiated (G3) endometrioid adenocarcinoma in Japan. Jpn J Clin Oncol 2005 35 : 23 7.
4. Hecht JL, Mutter GL. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol 2006 24 : 4783 91.
5. Ioachin E. Immunohistochemical tumour markers in endometrial carcinoma. Eur J Gynaecol Oncol 2005 26 : 363 71.
6. Reid-Nicholson M, Iyengar P, Hummer AJ, Linkov I, Asher M, Soslow RA. Immunophenotypic diversity of endometrial adenocarcinomas: implications for differential diagnosis. Mod Pathol 2006 19 : 1091 100.
7. Bignotti E, Tassi RA, Calza S et al. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. Gynecol Oncol 2006 103 : 405 16.
8. Tassi RA, Bignotti E, Rossi E et al. Overexpression of mammaglobin B in epithelial ovarian carcinomas. Gynecol Oncol 2007 105 : 578 85.
9. Becker RM, Darrow C, Zimonjic DB, Popescu NC, Watson MA, Fleming TP. Identification of mammaglobin B, a novel member of uteroglobin gene family. Genomics 1998 54 : 70 8.
10. Stoeckelhuber M, Messmer EM, Schmidt C, Xiao F, Schubert C, Klug J. Immunohistochemical analysis of secretoglobin SCGB 2A1 expression in human ocular glands and tissues. Histochem Cell Biol 2006 126 : 103 9.
11. Xiao F, Mirwald A, Papaioannou M, Baniahmad A, Klug J. Secretoglobin 2A1 is under selective androgen control mediated by a peculiar binding site for Sp family transcription factors. Mol Endocrinol 2005 19 : 2964 78.
12. Sjodin A, Guo D, Lund-Johansen M et al. Secretoglobins in the human pituitary: high expression of lipophilin B and its down-regulation in pituitary adenomas. Acta Neuropathol (Berl) 2005 109 : 381 6.
13. Adib TR, Henderson S, Perrett C et al. Predicting biomarkers for ovarian cancer using gene-expression microarrays. Br J Cancer 2004 9 : 686 92.
14. Hibbs K, Skubitz KM, Pambuccian SE et al. Differential gene expression in ovarian carcinoma: identification of potential biomarkers. Am J Pathol 2004 165 : 397 414.
15. Nissan A, Jager D, Roystacher M et al. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients. Br J Cancer 2006 94 : 681 5.
16. Okami J, Dohno K, Sakon M et al. Genetic detection for micrometastasis in lymph node of biliary tract carcinoma. Clin Cancer Res 2000 6 : 2326 32.
17. Bernstein JL, Godbold JH, Raptis G et al. Identification of mammaglobin as a novel serum marker for breast cancer. Clin Cancer Res 2005 11 : 6528 35.
18. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007 57 : 43 66.
19. Nur S, Chuang L, Ramaswamy G. Immunohistochemical characterization of cancer antigen in uterine cancers. Int J Gynecol Cancer 2006 16 : 1903 10.
20. Chung HH, Kim JW, Park NH, Song YS, Kang SB, Lee HP. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Acta Obstet Gynecol Scand 2006 85 : 1501 5.
21. Powell JL, Hill KA, Shiro BC, Diehl SJ, Gajewski WH. Preoperative serum CA-125 levels in treating endometrial cancer. J Reprod Med 2005 50 : 585 90.
22. Roncella S, Ferro P, Bacigalupo B et al. Relationship between human mammaglobin mRNA expression in breast cancer tissue and clinico-pathologic features of the tumors. J Exp Clin Cancer Res 2006 25 : 65 72.
23. Span PN, Waanders E, Manders P et al. Mammaglobin is associated with low-grade, steroid receptor-positive breast tumors from postmenopausal patients, and has independent prognostic value for relapse-free survival time. J Clin Oncol 2004 22 : 691 8.
24. Jaramillo A, Narayanan K, Campbell LG et al. Recognition of HLA-A2-restricted mammaglobin-A-derived epitopes by CD8+ cytotoxic T lymphocytes from breast cancer patients. Breast Cancer Res Treat 2004 88 : 29 41.